25.09.2025
How This Biomarker Can Detect Sepsis 3 Days Early
During this podcast, Patrick Pestalozzi shared his experience as Abionic CEO. Abionic is on a mission to transform sepsis diagnoses through the use of nanofluids, and their flagship product, abioSCOPE®, a near-patient rapid diagnostic platform, delivers lab-quality results from a drop of blood within minutes, providing valuable clinical insights and actionable information at the point-of-care.